PHIBRO ANIMAL HEALTH CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations $49.2m $32.6m $2.4m $48.3m
Net Income (Loss) Attributable to Parent $82.7m $64.6m $64.9m $54.7m $33.6m $54.4m $49.2m $32.6m $2.4m $48.3m
Net Income (Loss) Available to Common Stockholders, Basic $49.2m $32.6m $2.4m $48.3m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $49.2m $32.6m $2.4m $48.3m
Depreciation, Depletion and Amortization $23.5m $26.0m $26.9m $27.6m $32.3m $31.9m $32.7m $34.0m $36.2m $45.6m
Depreciation $17.7m $19.9m $21.0m $21.4m $23.2m $23.2m $23.8m $24.3m $26.5m $37.8m
Amortization of Debt Issuance Costs $590k $727k $1.0m $2.0m
Amortization of Debt Issuance Costs and Discounts $989k $1.0m $883k $882k $882k $833k
Amortization of Intangible Assets $5.6m $6.0m $5.9m $6.1m $8.9m $8.7m $8.9m $9.7m $9.7m $7.8m
Capitalized Computer Software, Amortization $1.5m $1.2m $1.0m $1.3m $1.0m $1.5m $1.4m $1.4m
Amortization Cash Flow $8.9m $9.7m $9.7m $7.8m
Amortization Of Intangibles $8.9m $9.7m $9.7m $7.8m
Depreciation Amortization Depletion $32.7m $34.0m $36.2m $45.6m
Deferred Income Tax Expense (Benefit) ($22.2m) ($28k) $6.4m ($105k) $8.1m ($2.2m) ($803k) ($2.9m) ($12.0m) ($4.8m)
Deferred Income Tax ($806k) ($2.8m) ($7.8m) ($4.9m)
Deferred Tax ($806k) ($2.8m) ($7.8m) ($4.9m)
Share-based Payment Arrangement, Noncash Expense $2.3m $2.3m $1.1m $475k $717k
Impairment of Intangible Assets, Finite-lived $885.0m
Asset Impairment Charge $0 $0 $5.3m
Gain (Loss) on Extinguishment of Debt ($2.6m) $0
Income Tax Expense (Benefit) ($6.0m) $15.9m $23.2m $16.8m $22.0m $12.1m $23.2m $21.5m $8.5m $19.7m
Interest Expense Nonoperating $23.0m $37.2m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $13.1m $2.8m $11.9m $23.7m ($28.7m) $18.2m $23.6m ($5.3m) $8.7m $55.2m
Increase (Decrease) in Inventories $16.4m ($5.4m) $24.3m $21.0m $12.9m $12.5m $47.0m $11.2m ($2.6m) $44.3m
Increase (Decrease) in Accounts Payable ($3.2m) ($3.1m) $2.4m $12.1m ($7.7m) $3.2m $26.4m ($22.8m) $12.0m $45.6m
Accretion Expense $1.5m $1.4m $1.1m $0
Foreign Currency Transaction Gain (Loss), before Tax $7.6m $113k $1.1m $55k ($826k) $4.5m $5.2m ($2.5m) ($23.9m) ($7.9m)
Foreign Currency Transaction Gain (Loss), Unrealized $7.7m $867k $635k $1.9m $2.5m $9.7m $4.8m $10.4m ($13.1m) ($600k)
Gain (Loss) Related to Litigation Settlement $899k $2.9m
General and Administrative Expense $38.5m
Goodwill $21.1m $24.0m $27.3m $27.3m $52.7m $52.7m $53.2m $53.3m $54.6m $59.6m
Pension Cost (Reversal of Cost) $4.4m $1.9m
Pension Expense (Reversal of Expense), Noncash $1.7m $0 $0 $10.7m
Revenue from Contract with Customer, Including Assessed Tax $828.0m
Beginning Cash Position $50.2m $74.2m $41.3m $70.6m
Cash Flow From Continuing Financing Activities $16.3m $27.0m ($6.8m) $207.1m
Cash Flow From Continuing Investing Activities ($22.6m) ($74.0m) ($48.2m) ($288.7m)
Change In Account Payable $26.4m ($22.8m) $12.0m $45.6m
Change In Accrued Expense $3.2m ($5.7m) $12.2m $47.2m
Change In Inventory ($47.0m) ($11.2m) $2.6m ($44.3m)
Change In Other Current Assets ($3.5m) ($6.7m) $15.0m ($14.8m)
Change In Payable $26.4m ($22.8m) $12.0m $45.6m
Change In Payables And Accrued Expense $29.5m ($28.6m) $24.2m $92.7m
Change In Receivables ($23.6m) $5.3m ($8.7m) ($55.2m)
Change In Working Capital ($44.6m) ($41.1m) $33.1m ($21.6m)
Changes In Account Receivables ($23.6m) $5.3m ($8.7m) ($55.2m)
Changes In Cash $25.4m ($33.7m) $32.6m ($1.4m)
End Cash Position $74.2m $41.3m $70.6m $68.0m
Financing Cash Flow $16.3m $27.0m ($6.8m) $207.1m
Free Cash Flow ($5.4m) ($38.5m) $46.4m $41.8m
Investing Cash Flow ($22.6m) ($74.0m) ($48.2m) ($288.7m)
Net Business Purchase And Sale ($13.5m) $0 ($3.3m) ($286.5m)
Net Foreign Currency Exchange Gain Loss ($4.8m) ($10.4m) $13.1m $600k
Operating Gains Losses ($6.0m) ($10.4m) $23.8m $600k
Other Non Cash Items $1.2m $1.1m ($537k) $6.1m
Pension And Employee Benefit Expense $0 $0 $10.7m $0
Purchase Of Business ($13.5m) $0 ($3.3m) ($286.5m)
Stock Based Compensation $0 $0 $475k $717k
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement ($1.7m) $0 $0 ($10.7m)
Net Cash Provided by (Used in) Operating Activities $37.2m $98.4m $70.0m $47.2m $59.3m $48.3m $31.6m $13.3m $87.6m $80.1m
Cash flows from investing activities:
Capital Expenditure ($37.0m) ($51.8m) ($41.2m) ($38.3m)
Capital Expenditure Reported $36.4m $20.9m $18.5m $29.9m $34.0m $29.3m ($37.0m) ($51.8m) ($41.2m) ($38.3m)
Payments to Acquire Businesses, Net of Cash Acquired $3.3m $286.5m
Net Investment Purchase And Sale $27.4m ($23.0m) ($4.0m) $35.0m
Purchase Of Investment ($64.1m) ($40.0m) ($65.5m) ($14.0m)
Sale Of Investment $91.5m $17.0m $61.5m $49.0m
Payments for (Proceeds from) Other Investing Activities ($137k) $1.1m $1.1m $404k $796k $1.3m ($620k) ($776k) ($326k) ($1.1m)
Net Other Investing Changes $620k $776k $326k $1.1m
Net Cash Provided by (Used in) Investing Activities ($84.6m) ($14.1m) ($120.4m) ($18.6m) ($22.6m) ($74.0m) ($48.2m) ($288.7m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $250.0m
Issuance Of Debt $297.0m $326.0m $276.0m $1.2b
Long Term Debt Issuance $297.0m $326.0m $276.0m $1.2b
Net Issuance Payments Of Debt $40.6m $42.7m $12.7m $236.0m
Net Long Term Debt Issuance $40.6m $42.7m $12.7m $236.0m
Long Term Debt Payments ($256.4m) ($283.3m) ($263.3m) ($946.0m)
Repayment Of Debt ($256.4m) ($283.3m) ($263.3m) ($946.0m)
Proceeds from Issuance of Common Stock $4.0m $5.5m $5.7m $1.1m
Payments of Ordinary Dividends, Common Stock $16 $16 $16 $19 $19 $19 $19 $19 $19 $19
Cash Dividends Paid ($19.4m) ($19.4m) ($19.4m) ($19.4m)
Common Stock Dividend Paid ($19.4m) ($19.4m) ($19.4m) ($19.4m)
Net Other Financing Charges ($4.8m) $3.7m ($31k) ($9.4m)
Net Cash Provided by (Used in) Financing Activities ($11.8m) ($4.1m) $40.9m ($17.0m) $16.3m $27.0m ($6.8m) $207.1m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($1.4m) $754k ($3.3m) ($1.1m)
Effect Of Exchange Rate Changes ($1.4m) $754k ($3.3m) ($1.1m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($21.2m) $13.9m $24.0m ($33.0m) $29.3m ($2.6m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $74.2m $41.3m $70.6m $68.0m
Cash, Cash Equivalents, and Short-term Investments $91.6m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported $24.0m ($33.0m) $29.3m ($2.6m)
Interest Paid, Excluding Capitalized Interest, Operating Activities $11.2m $12.2m $11.6m $10.8m $11.2m $14.6m $17.3m $32.1m
Income Taxes Paid, Net $16.8m $14.8m $15.2m $16.2m $20.9m $19.4m $17.9m $20.4m $15.4m $13.4m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.